<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00955643</url>
  </required_header>
  <id_info>
    <org_study_id>HBOT900208-06</org_study_id>
    <nct_id>NCT00955643</nct_id>
  </id_info>
  <brief_title>Periodontal Treatment Associated With Hyperbaric Oxygen Therapy</brief_title>
  <official_title>Periodontal Therapy in Severe Cases of Periodontitis: Preliminary Findings of Non-surgical Instrumentation With or Without Hyperbaric Oxygen Therapy (HBOT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Escola Bahiana de Medicina e Saude Publica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Escola Bahiana de Medicina e Saude Publica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the clinical effect of hyperbaric oxygen therapy (HBOT) adjunctively to scaling&#xD;
      and root planing (SRP) in the treatment of severe case of chronic periodontitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Materials and Methods: In 20 patients diagnosed with severe generalized chronic periodontitis&#xD;
      (pockets&gt;7mm) with bleeding on probing, SRP was rendered in all pockets. Additionally, five&#xD;
      consecutive hyperbaric sessions were administered in 10 patients after random allocation&#xD;
      (SRP+HBOT). Clinical parameters were assessed at baseline up to 6 months: plaque index (PI),&#xD;
      bleeding on probing, probing depth, clinical attachment level and BANA test.&#xD;
&#xD;
      Results: SRP+HBOT resulted in greater probing reduction and attachment gain than SRP alone 3&#xD;
      months after treatment (p&lt;0.001). The BANA test was negative after 1 week only for sites in&#xD;
      the SRP+HBOT group (p&lt;0.05). However SRP+HBOT failed to show a significant difference from&#xD;
      SRP group after 3 months were all BANA sites became negative (p&gt;0.05).&#xD;
&#xD;
      Conclusion: These preliminary data suggest that hyperbaric oxygen therapy had a short-term&#xD;
      beneficial effect on pocket reduction and bacterial elimination, and may be considered a&#xD;
      potential therapy option to improve the clinical outcomes of scaling in severe cases of&#xD;
      chronic periodontitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date type="Actual">April 2003</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>hyperbaric therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperbaric therapy by oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dental scaling and root planing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dental scaling and cleaning</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxygen</intervention_name>
    <arm_group_label>hyperbaric therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>other</intervention_name>
    <arm_group_label>dental scaling and root planing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  This preliminary (pilot) study was designed with twenty subjects (12 men, 8 women,&#xD;
             mean age 37.3 years) selected from a pool of 360 patients referred to the Periodontal&#xD;
             Clinic of the School of Dentistry at Bahian Science Foundation (FBDC, Bahia, Brazil).&#xD;
&#xD;
          -  The patients had an initial diagnosis of severe generalized chronic periodontitis (AAP&#xD;
             1999).&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients were excluded according to the following criteria:&#xD;
&#xD;
               -  smoking&#xD;
&#xD;
               -  pregnancy or lactation&#xD;
&#xD;
               -  antibiotics or periodontal treatment within the last 6 months&#xD;
&#xD;
               -  a diagnosis of aggressive periodontitis&#xD;
&#xD;
               -  trauma from occlusion or endodontic lesions&#xD;
&#xD;
          -  According to an accurate clinical examination performed by a hyperbaric medical doctor&#xD;
             (MD), the HBOT contra-indications (Iazzeti &amp; Mantovani 1998) served as exclusion&#xD;
             criteria.&#xD;
&#xD;
          -  The only absolute contraindication to hyperbaric oxygen therapy was from patients with&#xD;
             untreated pneumothorax&#xD;
&#xD;
          -  Relative contraindications were considered:&#xD;
&#xD;
               -  upper respiratory infections&#xD;
&#xD;
               -  high fevers&#xD;
&#xD;
               -  emphysema with CO2 retention&#xD;
&#xD;
               -  historic of thoracic surgery&#xD;
&#xD;
               -  malignant disease and middle ear barotrauma&#xD;
&#xD;
          -  Patients taking or have recently taken the following drugs:&#xD;
&#xD;
               -  doxorubicin (Adriamycin®)&#xD;
&#xD;
               -  disulfiram (Antabuse®)&#xD;
&#xD;
               -  Cis-platinum and mafenide acetate (Sulfamylon®).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>EBMSP Central Clinic</name>
      <address>
        <city>Salvador</city>
        <state>Bahia</state>
        <zip>40000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <study_first_submitted>August 7, 2009</study_first_submitted>
  <study_first_submitted_qc>August 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2009</study_first_posted>
  <last_update_submitted>August 7, 2009</last_update_submitted>
  <last_update_submitted_qc>August 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>EBMSP</name_title>
    <organization>Bahiana</organization>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>hyperbaric oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

